Trial site
Valley Retina Institute
- 10running trials
- 7closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration12 trials
- Diabetic eye disease3 trials
- Glaucoma1 trial
- Retinitis pigmentosa1 trial
- Phase
- Phase 35 trials
- Phase 12 trials
- Phase 22 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed7 trials
- Active, not recruiting6 trials
- Recruiting3 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Ocugen4 trials
- AiViva BioPharma, Inc.1 trial
- Allgenesis Biotherapeutics Inc.1 trial
- Apellis Pharmaceuticals, Inc.1 trial
- Astellas Institute for Regenerative Medicine1 trial
- and 9 more
Running trials
Recruiting
Recruiting
Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)
Active, not recruiting
Active, not recruiting
A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa
Active, not recruiting
Active, not recruiting
Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy
Recruiting
A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (GLOBALIGHT)
Active, not recruiting
A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease
Active, not recruiting
Enrolling by invitation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Macular degeneration4 recruiting
Closed trials
Completed
Completed
Completed
Completed
A Single Ascending Dose Cohort Study of AG-73305 in DME Patients
Completed
Completed
Recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026